Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries
Objective To clarify the impact of Japan’s Clinical Trials Act (CTA), which was enacted in April 2018, on subsequent clinical trial activity through an analysis of Japanese registry data.Design Retrospective database study.Setting We extracted information on clinical intervention studies registered...
Saved in:
Main Authors: | Hiroyuki Taruno, Mari S Oba, Osamu Takizawa, Kayoko Kikuchi, Kazuaki Matsui, Mayumi Shikano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/7/e059092.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cuban Public Registry of Clinical Trials: First of the World Health Organization in America
by: Olga Lidia Cuevas Pérez, et al.
Published: (2013-04-01) -
Discrepancies in reported results between trial registries and journal articles for AI clinical researchResearch in context
by: Zixuan He, et al.
Published: (2025-02-01) -
Challenges for funders in monitoring compliance with policies on clinical trials registration and reporting: analysis of funding and registry data in the UK
by: Rachel L Knowles, et al.
Published: (2020-02-01) -
Publication of studies registered in Clinical Trials Registry of India: An audit of mood disorder research protocols from 2009-2019
by: Vikas Menon, et al.
Published: (2023-01-01) -
Clinical Trials Committee -- An update
by: Helen Ramsdale
Published: (2003-01-01)